QSE 10 — Facilities and Safety

Key Concepts

Key Concepts: This QSE addresses the safety and adequacy of areas where the work required by these CT Standards is performed. This includes occupational safety, biohazardous material disposal, environmental monitoring, and compliance with applicable local and national regulations.

Key Terms
Environmental Monitoring: Policies, processes, and procedures used for monitoring any or all of the following: temperature, humidity, particulates, and microbial contamination in a specific area. Where appropriate, the program shall include sampling sites, frequency of sampling, and
investigative and corrective actions that should be followed when specified limits are exceeded.

Executive Management: The highest-level personnel within an organization, including employees, clinical leaders, and independent contractors, who have responsibility for the operations of the organization and who have the authority to establish or change the organization’s quality policy. Executive management may be an individual or a group of
individuals.

Organization: An institution, or a location or operational area within that organization; the entity assessed by the AABB and receiving AABB accreditation for specific activities.

Examples of Objective Evidence:

  • Policies, processes, and procedures related to this chapter.
  • Safe environmental conditions for all individuals in the organization.
  • Local, state, and national regulations being followed.
  • Proper discard of hazardous and potentially hazardous materials.
  • Personal protective equipment (PPE) is available and in use.

10.0 Facilities and Safety

The organization shall ensure safe environmental conditions.The work area shall be suitable for the activities performed.Safety programs shall meet local, state, and national regulations.

This standard requires that the facility ensure safe and adequate environmental conditions in the workplace. Specifically, this standard requires that the facility have a program that is designed to minimize risks to the health and safety of its employees, donors, volunteers, and patients. Implicit in this standard is the requirement that suitable quarters, environment, and equipment be available to maintain safe operations.

The standard specifically requires processes for biological, chemical, and radiation safety, where
applicable, as well as a system for monitoring training and compliance with those processes.
The standard also requires that products be handled and disposed of in a manner that is designed to prevent the potential for human exposure to infectious agents. Documentation of disposal of unused products should be maintained. (SS)

The committee revised standard 10.0 based on updates to the AABB Quality System Essentials. (SC)

10.1 Safe Environment

The organization shall minimize and respond to environmentally related risks to the health and  safety of all individuals and products or services. Suitable quarters, environment, and equipment shall be available to maintain safe operations.

The committee revised standard 10.1 based on updates to the AABB Quality System Essentials. (SC)

10.1.1

Policies, processes, and procedures shall identify and address the hazards present in the facility—including biological, chemical, and, where applicable, radiation safety—and appropriate intervention to limit exposure. The facility shall maintain a system for monitoring training and compliance.

10.1.2

Biohazardous materials shall be handled and discarded in a manner that minimizes the potential for human exposure to infectious agents.

10.1.3

Where liquid nitrogen is present, specific hazards shall be addressed.

10.1.3.1

The facility shall have a system in place to monitor oxygen levels and an alarm system set to activate under conditions that will allow action to be taken.

Adverse health effects begin when the oxygen level of air reaches “oxygen-deficient” levels of below 19.5% oxygen. Between 16% and 19.5%, symptoms can include increased breathing rates, accelerated heartbeat, impaired thinking, and poor coordination.

To be effective, the system should monitor continuously and activate both audible and visual alarms under conditions that will allow action to be taken before there are adverse consequences to humans in the area.

Refer to regulations defined by the local Competent Authority. (SS)

10.1.3.1.1

[Cord blood applicable]

Alarm activation shall require personnel to investigate and document the condition activating the alarm and to take immediate corrective action as necessary.

Adverse health effects begin when the oxygen level of air reaches “oxygen-deficient” levels of below 19.5% oxygen. Between 16% and 19.5%, symptoms can include increased breathing rates, accelerated heartbeat, impaired thinking, and poor coordination.

To be effective, the system should monitor continuously and activate both audible and visual alarms under conditions that will allow action to be taken before there are adverse consequences to humans in the area.

Refer to regulations defined by the local Competent Authority. (SS)

10.1.4 Environmental Controls

[Cord blood applicable]

The facility shall design, approve, and implement an environmental control system that:

  1. Optimizes donor, patient, and employee safety.
  2. Ensures product integrity and safety.
  3. Monitors cleaning or sanitation processes to minimize and mitigate contamination or accidental exposure to infectious disease agents.

#3 - The committee edited standard 10.1.4 for completeness and clarity through the inclusion of the clause, “Monitors cleaning or sanitation processes to…” (SC)

10.1.4.1

[Cord blood applicable]

The degree of environmental monitoring and controls shall be specific to the cellular therapy product manipulation performed.

For “351 HCT/Ps,” regulated as drugs, clean-room certification must be maintained according to ISO 14644 (International Organization for Standardization) and GMP standards based on risk level. Critical processes require Grade A/ISO 5 areas with a maximum of 3520 particles 0.5 microns per m3.

Required monitoring components and frequencies:

  1. Environmental controls:
    -Temperature, humidity, differential pressure monitoring.
    -HEPA (high-efficiency particulate air) filter integrity testing.
    -Air exchange rates verification.
    -Airflow visualization studies.
  2. Particle monitoring:
    -Continuous monitoring during critical operations.
    -Particle counts per ISO classification limits.
    -Regular verification of HEPA filter performance.
  3. Microbiological monitoring:
    -Active air sampling (action level: 1 CFU/m3 for ISO 5).
    -Surface monitoring with contact plates.
    -Personnel monitoring during operations.

Requalification schedule:

  • Grade A/B areas: every 6 months.
  • Grade C/D areas: annually.

Facilities must maintain complete documentation of monitoring results and implement immediate corrective actions for deviations. Changes affecting product safety, identity, purity, or potency require validation before implementation.

References

  1. Tanna J, McCann CD, Smith R, et al. Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting. Cytotherapy 2024;26:1421-8.
  2. US Food and Drug Administration. Guidance for industry: Sterile drug products produced by aseptic processing - current good manufacturing practice. Silver Spring, MD: CBER Office of Communication, Outreach, and Development, 2004.
  3. International Organization for Standardization. ISO 14644-1:2015. Cleanrooms and associated controlled environments - Part 1: Classification of air cleanliness by particle concentration. Geneva: ISO, 2015.
  4. International Organization for Standardization. ISO 14644-2:2015. Cleanrooms and associated controlled environments - Part 2: Monitoring to provide evidence of cleanroom performance related to air cleanliness by particle concentration. Geneva: ISO, 2015.
  5. International Organization for Standardization. ISO 14644-3:2019. Cleanrooms and associated controlled environments - Part 3: Test methods. Geneva: ISO, 2019.
  6. International Organization for Standardization. ISO 14644-4:2022. Cleanrooms and associated controlled environments - Part 4: Design, construction and start-up. Geneva: ISO, 2022. (SS)

10.1.5

The clinical facility shall have either on-site or ready access to services to manage anticipated adverse events and provide emergency medical care.

10.2

[Cord blood applicable]

The organization shall monitor adherence to biological, chemical, and radiation safety standards and regulations.

The committee added standard 10.2 based on updates to the AABB Quality System Essentials. (SC)

10.3 Handling and Discarding of Biological Materials

[Cord blood applicable]

Biological materials shall be handled and discarded in a manner that minimizes the potential for human exposure to infectious agents.

The committee added standard 10.3 based on updates to the AABB Quality System Essentials. (SC)

10.4 General Operational Controls

Access to facilities used for procurement, processing, preservation, and storage shall be limited to authorized individuals.

Excerpt of Reference Standard 6.2.9A Relevant to Facilities and Safety

Standard Record to Be Maintained Quality System Records Donor Eligibility/Management Issues Unit/Recipient Retention after
Creation (C) or
Final Disposition
(F) of Related
Product
Minimum Retention Time (in years)1
10.1.3.1.1 Alarm investigation X X X C 10
10.1.4, #3 Cleaning or sanitation processes X X X C 10
10.1.4.1 Environmental monitoring X X X C 10
10.2 Monitoring of biological, chemical,
and radiation safety
X X X C 10
10.3 Appropriate discard of products X X X C 10

1Applicable federal, state, or local law may exceed this period.